{"id":2333,"date":"2026-05-15T03:09:10","date_gmt":"2026-05-15T03:09:10","guid":{"rendered":"https:\/\/drsoniafawad.com\/?p=2333"},"modified":"2026-05-15T03:09:10","modified_gmt":"2026-05-15T03:09:10","slug":"ai-aided-colonoscopy-may-help-high-risk-colorectal-cancer-group","status":"publish","type":"post","link":"https:\/\/drsoniafawad.com\/?p=2333","title":{"rendered":"AI-aided colonoscopy may help high-risk colorectal cancer group"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-component=\"ArticleContent\">\n<div class=\"article__below-title\">\n<div class=\"mobile-trust-box\">\n<div class=\"row\">\n<div class=\"col-12 col-md-5 d-xl-none\">\n<div class=\"trust-box\">\n<div class=\"trust-box-logo d-none d-md-block\">\n            <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n          <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"col-12 col-md-6 offset-md-1 offset-xl-0 col-xl-12\">\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse ufb81102d5caa49f4ace816ec2077ec2d\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260508\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<h2>Key takeaways:<\/h2>\n<ul>\n<li>A computer-aided detection system improved adenoma detection rate and had higher adenomas per colonoscopy among FIT-positive patients.<\/li>\n<li>The improvement was mostly driven by diminutive adenoma detection.<\/li>\n<\/ul>\n<p>AI-assisted colonoscopy could detect diminutive adenomas at higher rates than standard colonoscopy, which could be beneficial to populations at high risk for colorectal cancer.<\/p>\n<p>A randomized trial of more than 1,300 individuals in Taiwan showed computer-aided detection (CAD) was noninferior to standard colonoscopy for adenoma detection in the general population, but had a 39% higher likelihood of detecting adenomas among patients with positive <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20251027\/positive-interval-fit-after-colonoscopy-highlights-need-for-adequate-followup\" id=\"rId11\" target=\"_blank\">fecal immunochemical test<\/a> (FIT) results.<\/p>\n<figure class=\"figure article__og-image\">&#13;\n    <picture>&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.webp?w=476\" media=\"(max-width: 768px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.webp?w=800\" media=\"(max-width: 992px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.webp?w=595\" media=\"(max-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.webp?w=476\" media=\"(min-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.webp?w=476\">&#13;<br \/>\n&#13;<br \/>\n      <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/hemonc\/misc\/infographics\/hot-infographics\/2026\/05_may\/hot0426hsu_graphic_01_web.jpg?w=800\" alt=\"AI-assisted colonoscopy improved adenoma detection rate among patients at high risk for colorectal cancer IG\" class=\"figure-img img-fluid\" width=\"800\"\/>&#13;<br \/>\n    <\/source><\/source><\/source><\/source><\/source><\/picture>&#13;<figcaption class=\"figure-caption\">&#13;<br \/>\n      Data derived from Hsu WF, et al. <i>JAMA Netw Open<\/i>. 2026;doi:10.1001\/jamanetworkopen.2026.4881.&#13;<br \/>\n    <\/figcaption>&#13;<br \/>\n  <\/figure>\n<p>\u201cCAD should be strategically deployed as a precision tool for high-risk cohorts and as a quality-standardization asset within organized screening programs,\u201d <b>Han-Mo Chiu, MD, PhD,<\/b> attending physician at National Taiwan University Hospital, told Healio.<\/p>\n<p>\u201cIn FIT-positive patients, more is not just more. Finding more diminutive adenomas is clinically vital. Because these small lesions in high-risk patients have a higher propensity for advanced histology like [high-grade dysplasia (HGD)], using <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260421\/ai-highlights-link-between-earlyonset-colorectal-cancer-and-microbiome-socioeconomics\" id=\"rId12\" target=\"_blank\">AI<\/a> to maximize their detection directly addresses the risk of interval cancers that might otherwise be overlooked in a manual exam. Crucially, this enhanced detection is achieved without over-resection.\u201d<\/p>\n<h2>\u2018A unique high-risk cohort\u2019<\/h2>\n<p>Adenoma detection rate has a significant association with interval <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20260402\/ai-flags-which-patients-with-ulcerative-colitis-may-progress-to-colorectal-cancer\" id=\"rId13\" target=\"_blank\">colorectal cancer<\/a>, according to study background.<\/p>\n<p>Prior studies have shown every 1% increase in detection decreases risk for colorectal cancer 3%, but up to 26% of adenomas and 27% of serrated polyps are missed on standard colonoscopy, most of which are classified as diminutive ( 5 mm) or small (6-9 mm).<\/p>\n<p>CAD has been shown to increase detection of smaller adenomas.<\/p>\n<p>\u201cA major critique is that CAD primarily increases the detection of adenomas less than 1 cm, which some argue may have limited clinical impact in the general population,\u201d Chiu said. \u201cHowever, we recognized that FIT-positive individuals represent a unique high-risk cohort. They tend to have a higher multiplicity of adenomas, and importantly, even adenomas smaller than 1 cm in this population carry a substantially higher likelihood of advanced histology, such as HGD.<\/p>\n<p>\u201cOur previous study in Taiwan comparing adenomas detected in FIT-positive individuals with those identified in the general population undergoing direct colonoscopy demonstrated that the former have a significantly higher risk of HGD and invasive cancer, even within the same size category of less than 1 cm. This raises the question of whether the common criticism \u2014 that CAD mainly increases detection of small adenomas and therefore has limited impact on future colorectal cancer risk \u2014 is applicable in the FIT-screening setting.\u201d<\/p>\n<p>Chiu and colleagues conducted a multicenter trial in Taiwan to investigate.<\/p>\n<p>They randomly assigned 1,356 adults aged 40 to 79 years (mean age, 60 years; standard deviation, 9.4; 50% women) undergoing <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260305\/qa-concerning-colorectal-cancer-trends-reversible-with-screening-lifestyle-changes\" id=\"rId14\" target=\"_blank\">colonoscopy<\/a> for positive FIT results, gastrointestinal symptoms, screening or surveillance for a history of polyps, to receive either CAD-assisted (n = 675) or standard colonoscopy (n = 681).<\/p>\n<p>Adenoma detection rate served as the primary endpoint. Researchers defined detection rate as the proportion of patients who had at least one histologically confirmed adenoma.<\/p>\n<p>Adenomas per colonoscopy, postpolypectomy surveillance intervals, and sessile serrated lesion detection rate served as secondary endpoints.<\/p>\n<h2>\u2018Critical finding\u2019<\/h2>\n<p>Overall, researchers observed noninferiority in adenoma detection rate between CAD (58.5%) and standard colonoscopy (53.1%; <i>P<\/i> = .01), but the difference did not reach statistical significance (<i>P<\/i> = .05).<\/p>\n<p>However, among patients with positive FIT results, the CAD cohort had a significantly higher adenoma detection rate (65.3% vs. 57.4%; adjusted OR = 1.39; 95% CI, 1.05-1.86).<\/p>\n<p>\u201cThis is a critical finding,\u201d Chiu said. \u201cThe AI\u2019s ability to detect more of these subcentimeter adenomas in this trial will hopefully translate into a highly meaningful clinical benefit for this specific group.\u201d<\/p>\n<p>CAD helped identify significantly more adenomas per colonoscopy overall (mean, 1.41 vs. 1.2; <i>P<\/i> = .01) and in the FIT subgroup (mean, 1.64 vs. 1.39; <i>P<\/i> = .01), the difference stemming from detection of diminutive adenomas.<\/p>\n<p>The CAD group also had significantly more polyps per colonoscopy (mean, 1.97 vs. 1.71; <i>P<\/i> = .005).<\/p>\n<p>The CAD and standard colonoscopy groups had similar advanced adenomas per colonoscopy, nonneoplastic polypectomy rates, and sessile serrated lesion detection rates.<\/p>\n<p>However, withdrawal time was significantly longer with CAD than standard colonoscopy (mean, 9.14 minutes vs. 8.32 minutes; <i>P<\/i> &lt; .001).<\/p>\n<p>Patients who underwent CAD-assisted colonoscopy had a significantly higher likelihood of being assigned to U.S. Multi-Society Task Force intensive surveillance of 3 to 5 years (10.4% vs. 7.2%; aOR = 1.5; 95% CI, 1.01-2.21). Patients in the FIT subgroup had even greater odds (13.2% vs. 7.3%; aOR = 1.94; 95% CI, 1.22-3.09).<\/p>\n<p>\u201cWhat surprised us the most was how the AI acted as a great equalizer among physicians,\u201d Chiu said. \u201cThe benefit of CAD was most pronounced among junior endoscopists, significantly improving their performance, while senior experts saw numerical, but nonsignificant, gains. Furthermore, we were pleased to see that CAD did not increase the nonneoplastic polypectomy rate. This means the AI did not cause our endoscopists to over-resect normal tissue, proving that clinical judgment remained intact alongside the AI assistance.\u201d<\/p>\n<p>Researchers acknowledged study limitations, including use of a single CAD system and not being able to blind endoscopists in the study arm.<\/p>\n<p>\u201cI would like to emphasize the rigorous, high-ceiling setting of our trial,\u201d Chiu said. \u201cWe conducted this study across centers where the baseline adenoma detection rate was already exceptionally high \u2014 over 50% for all indications of colonoscopy. Demonstrating that AI can still provide measurable clinical benefits in such an optimized environment \u2014 specifically by catching high-risk subcentimeter lesions in FIT-positive patients \u2014 proves that this technology is not just a crutch for low-performing centers. It is a tool that pushes the boundaries of excellence.\u201d<\/p>\n<h2>\u2018Establish clear criteria\u2019<\/h2>\n<p>Chiu described three key components of future research.<\/p>\n<p>The first involves longitudinal follow-up. \u201cDoes the removal of these specific AI-detected lesions effectively reduce the long-term incidence and mortality of postcolonoscopy colorectal cancer?\u201d he asked. \u201cWe need tracking data to definitively confirm that increased detection translates to enhanced prevention.\u201d<\/p>\n<p>He also anticipated that, \u201calthough we were not able to demonstrate the superiority of AI in detecting HGD in adenomas smaller than 1cm in this trial \u2014 which would require a remarkably larger sample size \u2014 it would be expected to detect more such lesions if it is used across several tens of thousands of colonoscopies performed in our large-scale FIT screening setting.\u201d<\/p>\n<p>The following step involves health economics.<\/p>\n<p>\u201cBecause CAD shifts more patients into intensive 3-to-5-year surveillance intervals, we must conduct rigorous cost-effectiveness analyses,\u201d Chiu said. \u201cWe need to determine if the financial and operational burden of these additional surveillance colonoscopies is justified by the downstream clinical savings of preventing advanced cancers.\u201d<\/p>\n<p>Lastly, Chiu emphasized the importance of policy integration and updated guidelines.<\/p>\n<p>\u201cWe are actively looking at how to incorporate these evidence-based findings into updated guidelines of the Taiwan Colorectal Cancer Screening Program,\u201d he said. \u201cWe must establish clear criteria for when and for whom AI should be deployed \u2014 such as prioritizing its use for FIT-positive cohorts \u2014 to optimize both patient outcomes and the sustainability of the health care system.\u201d<\/p>\n<p>In an accompanying editorial in <i>JAMA Network Open<\/i>,<b> <\/b><b>Masashi Misawa, MD, PhD,<\/b> associate professor of gastroenterology at Showa Medical University in Japan, and colleagues described the need for \u201ccautious interpretation\u201d of the results, noting the \u201cexploratory\u201d nature of the FIT-positive subgroup analysis.<\/p>\n<p>\u201cThe evidence that CAD improves [adenoma detection rate] is well established,\u201d they wrote. \u201cWhat remains unproven is whether this improvement reduces [colorectal cancer] incidence \u2014 the outcome that ultimately matters. Future trials should move beyond [adenoma detection rate] as the primary endpoint and assess [postcolonoscopy colorectal cancer] incidence, advanced neoplasia over long-term follow-up, and cost-effectiveness in organized screening programs.\u201d<\/p>\n<h2>For more information:<\/h2>\n<p>      <b>Han-Mo Chiu, MD, PhD,<\/b> can be reached at <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260508\/mailto:hanmochiu@ntu.edu.tw\" id=\"rId15\" target=\"_blank\">hanmochiu@ntu.edu.tw<\/a>.<\/p>\n<p>\u00a0<\/p>\n<div class=\"article__content--footer\">\n<div class=\"publisher-logo\">\n    <span>Published by:<\/span><br \/>\n    <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&amp;h=24&amp;w=141&amp;hash=2F86D471C8514C0E334E329AA799E8B4\" class=\"logo-img\" height=\"24\" alt=\"hemonc today logo\" width=\"141\"\/>\n  <\/div>\n<div class=\"sources-references-disclosures\">\n<h3>Sources\/Disclosures<\/h3>\n<h2> Source: <\/h2>\n<p class=\"citation\">&#13;<br \/>\n  <a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847778\" id=\"rId10\" target=\"_blank\">Hsu WF, et al. <i>JAMA Netw Open<\/i>. 2026;doi:10.1001\/jamanetworkopen.2026.4881<\/a>.<\/p>\n<h2>Reference:<\/h2>\n<div class=\"disclosures\">\n<p>&#13;<br \/>\n        <strong> Disclosures: <\/strong>&#13;<br \/>\n        Chiu reports grant support from National Science and Technology Council. The other authors report no relevant financial disclosures. Misawa reports personal fees from Olympus Corp. and Cybernet Systems. Please see the study for all other authors\u2019 relevant financial disclosures.&#13;\n      <\/p>\n<\/p><\/div>\n<\/div>\n<p><!-- Healio AI Widget --><\/p>\n<div class=\"healio-ai-component-inline\" data-no-ads=\"true\" data-module-track-category=\"Healio AI\" data-module-track-action=\"Click\" data-module-track-label=\"Access Healio Ai from component - News_AI Component - In-Content (all devices)\">\n<div class=\"healio-ai-content\">\n    <img decoding=\"async\" src=\"https:\/\/m3.healio.com\/~\/media\/images\/healio-ai\/healio-ai_logo.svg\" alt=\"Healio AI\" class=\"healio-ai-logo\"\/><\/p>\n<p><strong>Ask a clinical question<\/strong> and tap into <strong>Healio AI&#8217;s knowledge<\/strong> base.<\/p>\n<ul>&#13;<\/p>\n<li>PubMed, enrolling\/recruiting trials, guidelines<\/li>\n<p>&#13;<\/p>\n<li>Clinical Guidance, Healio CME, FDA news<\/li>\n<p>&#13;<\/p>\n<li>Healio&#8217;s exclusive daily news coverage of clinical data<\/li>\n<p>&#13;\n    <\/ul>\n<p>    <button class=\"healio-ai-button\" onclick=\"window.location.href=\" https:=\"\">Learn more<\/button>\n  <\/div>\n<\/div>\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse ufb81102d5caa49f4ace816ec2077ec2d\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260508\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.healio.com\/news\/hematology-oncology\/20260508\/aiaided-colonoscopy-clinically-vital-for-patients-at-high-risk-for-colorectal-cancer\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#13; &#13; &#13; Add topic to email alerts&#13; &#13; &#13; Receive an email when new articles are posted on &#13; Please provide your email address to receive an email when new articles are posted on . &#8220;&#13; data-action=&#8221;subscribe&#8221;&gt;&#13; Subscribe&#13; We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: A computer-aided detection system improved adenoma detection rate and had higher adenomas per colonoscopy among FIT-positive patients. The improvement was mostly driven by diminutive adenoma detection. AI-assisted colonoscopy could detect diminutive adenomas at higher rates than standard colonoscopy, which could be beneficial to populations at high risk for colorectal cancer. A randomized trial of more than 1,300 individuals in Taiwan showed computer-aided detection (CAD) was noninferior to standard colonoscopy for adenoma detection in the general population, but had a 39% higher likelihood of detecting adenomas among patients with positive fecal immunochemical test (FIT) results. &#13; &#13;&#13;&#13;&#13;&#13;&#13; &#13; &#13; &#13;&#13; Data derived from Hsu WF, et al. JAMA Netw Open. 2026;doi:10.1001\/jamanetworkopen.2026.4881.&#13; &#13; \u201cCAD should be strategically deployed as a precision tool for high-risk cohorts and as a quality-standardization asset within organized screening programs,\u201d Han-Mo Chiu, MD, PhD, attending physician at National Taiwan University Hospital, told Healio. \u201cIn FIT-positive patients, more is not just more. Finding more diminutive adenomas is clinically vital. Because these small lesions in high-risk patients have a higher propensity for advanced histology like [high-grade dysplasia (HGD)], using AI to maximize their detection directly addresses the risk of interval cancers that might otherwise be overlooked in a manual exam. Crucially, this enhanced detection is achieved without over-resection.\u201d \u2018A unique high-risk cohort\u2019 Adenoma detection rate has a significant association with interval colorectal cancer, according to study background. Prior studies have shown every 1% increase in detection decreases risk for colorectal cancer 3%, but up to 26% of adenomas and 27% of serrated polyps are missed on standard colonoscopy, most of which are classified as diminutive ( 5 mm) or small (6-9 mm). CAD has been shown to increase detection of smaller adenomas. \u201cA major critique is that CAD primarily increases the detection of adenomas less than 1 cm, which some argue may have limited clinical impact in the general population,\u201d Chiu said. \u201cHowever, we recognized that FIT-positive individuals represent a unique high-risk cohort. They tend to have a higher multiplicity of adenomas, and importantly, even adenomas smaller than 1 cm in this population carry a substantially higher likelihood of advanced histology, such as HGD. \u201cOur previous study in Taiwan comparing adenomas detected in FIT-positive individuals with those identified in the general population undergoing direct colonoscopy demonstrated that the former have a significantly higher risk of HGD and invasive cancer, even within the same size category of less than 1 cm. This raises the question of whether the common criticism \u2014 that CAD mainly increases detection of small adenomas and therefore has limited impact on future colorectal cancer risk \u2014 is applicable in the FIT-screening setting.\u201d Chiu and colleagues conducted a multicenter trial in Taiwan to investigate. They randomly assigned 1,356 adults aged 40 to 79 years (mean age, 60 years; standard deviation, 9.4; 50% women) undergoing colonoscopy for positive FIT results, gastrointestinal symptoms, screening or surveillance for a history of polyps, to receive either CAD-assisted (n = 675) or standard colonoscopy (n = 681). Adenoma detection rate served as the primary endpoint. Researchers defined detection rate as the proportion of patients who had at least one histologically confirmed adenoma. Adenomas per colonoscopy, postpolypectomy surveillance intervals, and sessile serrated lesion detection rate served as secondary endpoints. \u2018Critical finding\u2019 Overall, researchers observed noninferiority in adenoma detection rate between CAD (58.5%) and standard colonoscopy (53.1%; P = .01), but the difference did not reach statistical significance (P = .05). However, among patients with positive FIT results, the CAD cohort had a significantly higher adenoma detection rate (65.3% vs. 57.4%; adjusted OR = 1.39; 95% CI, 1.05-1.86). \u201cThis is a critical finding,\u201d Chiu said. \u201cThe AI\u2019s ability to detect more of these subcentimeter adenomas in this trial will hopefully translate into a highly meaningful clinical benefit for this specific group.\u201d CAD helped identify significantly more adenomas per colonoscopy overall (mean, 1.41 vs. 1.2; P = .01) and in the FIT subgroup (mean, 1.64 vs. 1.39; P = .01), the difference stemming from detection of diminutive adenomas. The CAD group also had significantly more polyps per colonoscopy (mean, 1.97 vs. 1.71; P = .005). The CAD and standard colonoscopy groups had similar advanced adenomas per colonoscopy, nonneoplastic polypectomy rates, and sessile serrated lesion detection rates. However, withdrawal time was significantly longer with CAD than standard colonoscopy (mean, 9.14 minutes vs. 8.32 minutes; P &lt; .001). Patients who underwent CAD-assisted colonoscopy had a significantly higher likelihood of being assigned to U.S. Multi-Society Task Force intensive surveillance of 3 to 5 years (10.4% vs. 7.2%; aOR = 1.5; 95% CI, 1.01-2.21). Patients in the FIT subgroup had even greater odds (13.2% vs. 7.3%; aOR = 1.94; 95% CI, 1.22-3.09). \u201cWhat surprised us the most was how the AI acted as a great equalizer among physicians,\u201d Chiu said. \u201cThe benefit of CAD was most pronounced among junior endoscopists, significantly improving their performance, while senior experts saw numerical, but nonsignificant, gains. Furthermore, we were pleased to see that CAD did not increase the nonneoplastic polypectomy rate. This means the AI did not cause our endoscopists to over-resect normal tissue, proving that clinical judgment remained intact alongside the AI assistance.\u201d Researchers acknowledged study limitations, including use of a single CAD system and not being able to blind endoscopists in the study arm. \u201cI would like to emphasize the rigorous, high-ceiling setting of our trial,\u201d Chiu said. \u201cWe conducted this study across centers where the baseline adenoma detection rate was already exceptionally high \u2014 over 50% for all indications of colonoscopy. Demonstrating that AI can still provide measurable clinical benefits in such an optimized environment \u2014 specifically by catching high-risk subcentimeter lesions in FIT-positive patients<\/p>\n","protected":false},"author":1,"featured_media":2334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2333","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/2333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2333"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/2333\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/2334"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}